102 related articles for article (PubMed ID: 25929598)
1. Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome.
Grenda R; Jarmużek W; Rubik J; Migdał M; Pronicki M
Pediatr Transplant; 2015 Aug; 19(5):E115-20. PubMed ID: 25929598
[TBL] [Abstract][Full Text] [Related]
2. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
[TBL] [Abstract][Full Text] [Related]
3. A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome.
Spatafora M; Bellini T; Giordano C; Ghiggeri GM
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26661285
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
5. Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.
Bernard J; Bruel A; Allain-Launay E; Dantal J; Roussey G
Pediatr Transplant; 2018 Jun; 22(4):e13175. PubMed ID: 29569812
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type.
Chaudhuri A; Kambham N; Sutherland S; Grimm P; Alexander S; Concepcion W; Sarwal M; Wong C
Pediatr Transplant; 2012 Aug; 16(5):E183-7. PubMed ID: 21672106
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report.
Grenda R; Jarmużek W; Piątosa B; Rubik J
Pediatr Transplant; 2011 Sep; 15(6):E121-5. PubMed ID: 20331516
[TBL] [Abstract][Full Text] [Related]
8. Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.
Bitzan M; Anselmo M; Carpineta L
Pediatr Pulmonol; 2009 Sep; 44(9):922-34. PubMed ID: 19681063
[TBL] [Abstract][Full Text] [Related]
9. [Value of cyclosporine in the treatment of the recurrence of nephrosis after renal transplantation].
Ranchin B; Gagnadoux MF; Broyer M; Lehnert A; Juresco A; Chérif N; Jan D; Droz D; Gubler MC; Niaudet P
Nephrologie; 1996; 17(8):441-5. PubMed ID: 9036367
[TBL] [Abstract][Full Text] [Related]
10. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
[TBL] [Abstract][Full Text] [Related]
11. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
Salomon R; Gagnadoux MF; Niaudet P
Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
[TBL] [Abstract][Full Text] [Related]
12. New insights into the pathophysiology of idiopathic nephrotic syndrome.
Bruneau S; Dantal J
Clin Immunol; 2009 Oct; 133(1):13-21. PubMed ID: 19410518
[TBL] [Abstract][Full Text] [Related]
13. Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation.
Bernard J; Lalieve F; Sarlat J; Perrin J; Dehoux L; Boyer O; Godron-Dubrasquet A; Harambat J; Decramer S; Caillez M; Bruel A; Allain-Launay E; Dantal J; Roussey G
Pediatr Nephrol; 2020 Aug; 35(8):1499-1506. PubMed ID: 32306087
[TBL] [Abstract][Full Text] [Related]
14. Pre-emptive rituximab and plasma exchange does not prevent disease recurrence following living donor renal transplantation in high-risk idiopathic SRNS.
Shenoy M; Lennon R; Plant N; Wallace D; Kaur A
Pediatr Nephrol; 2020 Jun; 35(6):1081-1084. PubMed ID: 32124030
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
[TBL] [Abstract][Full Text] [Related]
16. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
[TBL] [Abstract][Full Text] [Related]
17. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
Hyla-Klekot L; Grenda R; Pulcer B
Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
[TBL] [Abstract][Full Text] [Related]
18. [Use of rituximab in the induction of remission of severe, resistant and recurrent form of polyangiitis associated with c-ANCA antibodies - case report].
Brodowska-Kania D; Rymarz A; Saracyn M; Geisler P; Niemczyk S
Pol Merkur Lekarski; 2015 Apr; 38(226):216-8. PubMed ID: 25938389
[TBL] [Abstract][Full Text] [Related]
19. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
20. Fatal pulmonary fibrosis after rituximab administration.
Chaumais MC; Garnier A; Chalard F; Peuchmaur M; Dauger S; Jacqz-Agrain E; Deschênes G
Pediatr Nephrol; 2009 Sep; 24(9):1753-5. PubMed ID: 19396468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
